Senior insider sale
TAYSHA GENE THERAPIES, INC. — senior position signals high conviction
$1.87M
400K shares
What this filing means
NAGENDRAN SUKUMAR plans to sell 400K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $1.87M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/10/2026ACC: 0001974158-26-000040
Director
Since Sep 2020
400K
Shares to sell
$1.87M
Approx. market value
200K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
RSU Grant
N/A
1/2/2025
49.43KStock Option Grant
N/A
1/2/2024
19.02KRSU Grant
N/A
1/2/2024
131.55KTotal acquired200K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2025 | RSU Grant N/A | 49.43K | — |
1/2/2024 | Stock Option Grant N/A | 19.02K | — |
1/2/2024 | RSU Grant N/A | 131.55K | — |
| Total | 200K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
200K
Market value
$942.7K
1/12/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
200K
Market value
$926.0K
4/10/2026
Total
Units
400K
Value
$1.87M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/12/2026 | 200K | $942.7K | — | Completed |
| Planned — Approximate Date | ||||
4/10/2026 | 200K | $926.0K | Nasdaq | Planned |
| Total | 400K | $1.87M | ||